Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: Henry Volquardsen who wrote (1098)	9/7/1998 1:37:00 PM
From: luis a. garcia	Respond to of 1115

Bud leedom sees a four dollar stock.... read about it at the ldaka page of my website... members.tripod.com enjoy luis

To: Henry Volquardsen who wrote (1098)	9/9/1998 5:42:00 PM
From: henry jakala	Read Replies (2) \| Respond to of 1115

biz.yahoo.com Wednesday September 9, 4:05 pm Eastern Time Company Press Release SOURCE: LIDAK Pharmaceuticals LIDAK Pharmaceuticals Reports Top Executives Form 4 Filings with Securities and Exchange Commission SAN DIEGO, Sept. 9 /PRNewswire/ -- LIDAK Pharmaceuticals (Nasdaq: LDAKA - news) reported today that board chairman George P. Rutland, president and CEO Gerald J. Yakatan, Ph.D. and vice president and CFO Gregory P. Hanson have filed Form 4s with the SEC reporting total purchases of 120,000 shares of LIDAK Class A common stock made during the past ten days.